Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Prepaid Assets (2017 - 2025)

Crinetics Pharmaceuticals (CRNX) has 8 years of Prepaid Assets data on record, last reported at $4.8 million in Q3 2025.

  • For Q3 2025, Prepaid Assets rose 229.09% year-over-year to $4.8 million; the TTM value through Sep 2025 reached $4.8 million, up 229.09%, while the annual FY2024 figure was $23.6 million, 2659.39% up from the prior year.
  • Prepaid Assets reached $4.8 million in Q3 2025 per CRNX's latest filing, down from $23.6 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $23.6 million in Q4 2024 and bottomed at $372000.0 in Q2 2023.
  • Average Prepaid Assets over 5 years is $5.4 million, with a median of $1.6 million recorded in 2022.
  • Peak YoY movement for Prepaid Assets: tumbled 95.22% in 2023, then surged 2690.22% in 2024.
  • A 5-year view of Prepaid Assets shows it stood at $912000.0 in 2021, then rose by 2.96% to $939000.0 in 2022, then fell by 8.73% to $857000.0 in 2023, then soared by 2659.39% to $23.6 million in 2024, then crashed by 79.67% to $4.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $4.8 million in Q3 2025, $23.6 million in Q4 2024, and $1.5 million in Q3 2024.